About Nanomi
Nanomi is a company based in Oldenzaal (Netherlands) founded in 2004 was acquired by Lupin in February 2014. Nanomi operates in a competitive market with competitors including Sirnaomics, Liquidia, Acorda, Genedit and NanoSyrinx, among others.
- Headquarter Oldenzaal, Netherlands
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Nanomi
Unlock access to complete
Funding Insights of Nanomi
Investors in Nanomi
Nanomi has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lupin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical products including generics, biosimilars, and APIs are manufactured.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nanomi
Financial Statements - Nanomi
Nanomi Comparisons
Competitors of Nanomi
Nanomi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sirnaomics, Liquidia, Acorda, Genedit and NanoSyrinx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
RNA-based therapeutics for cancer and fibrosis are developed.
|
|
| domain | founded_year | HQ Location |
Engineered particles & films for life and material sciences applications
|
|
| domain | founded_year | HQ Location |
Engaged in the development and commercialization of therapies that improve neurological function.
|
|
| domain | founded_year | HQ Location |
Genetic medicines are delivered using polymer nanoparticle platforms.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems to cell interiors are developed via nanosyringes.
|
|
| domain | founded_year | HQ Location |
Drug delivery solutions via single-walled carbon nanotubes are offered.
|
Frequently Asked Questions about Nanomi
Nanomi was founded in 2004.
Nanomi is headquartered in Oldenzaal, Netherlands. It is registered at Oldenzaal, Overijssel, Netherlands.
Okke Franssen is the current CEO of Nanomi.
Nanomi was founded in 2004 in Oldenzaal, Netherlands, as a subsidiary of Lupin Limited. Operations center on the drug delivery sector, where sustained release complex injectable products are formulated, developed, and manufactured. Microfluidic Monosphere Technology is employed to create uniform particles that enhance injectability and reduce injection pain. Business-to-business partnerships are pursued with pharmaceutical and biotech firms for high-value applications, though products are not distributed or marketed directly.
Nanomi's top competitors include Sirnaomics, Arcturus Therapeutics and Acorda.
Nanomi has 1 investor. Key investors include Lupin.